Quick Answer: GLP-1 injections can cause tiredness, classified as a common side effect affecting between 1 in 10 and 1 in 100 people, particularly at higher doses used for weight management
Regulatory status (as of April 2026) Retatrutide is not FDA approved and not EMA approved as of April 2026
Ro will update the tracker based on its own supply data, which is generated when the company's patients log that they have successfully picked up their medication at a pharmacy
Consumers Expectations about GLP-1 Drugs Economic Impact on Food System Players farmdoc daily (15):49, Department of Agricultural and Consumer Economics, University of Illinois at Urbana-Champaign, March 14, 2025
Furthermore, the review explores novel drug delivery strategies, such as microsphere encapsulation, injectable hydrogels, Fc-fusion, and oral small-molecule formulations, aimed at achieving sustained and controlled release to reduce dosing frequency and improve patient compliance
FeelGood GLP-1 Support: What 24/7 Access Actually Means The brand states 24/7 access to a dedicated team of specialists is included with the subscription, along with unlimited appointments and messaging